Your browser doesn't support javascript.
loading
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.
Morrow, Sarah A; Kruger, Paola; Langdon, Dawn; Alexandri, Nektaria.
Afiliação
  • Morrow SA; Department of Clinical Neurological Sciences, Western University, London, ON, Canada. sarah.morrow@albertahealthservices.ca.
  • Kruger P; Patient Advocate, Rome, Italy.
  • Langdon D; Department of Psychology, Health and Wellbeing, Royal Holloway, University of London, London, UK.
  • Alexandri N; Global Medical Affairs, Neurology and Immunology, The Healthcare Business of Merck KGaA, Darmstadt, Germany.
Neurol Ther ; 13(3): 497-499, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38376607
ABSTRACT
Cognitive symptoms affect disease management and activities of daily living for people living with multiple sclerosis (MS). This summary of research article summarises previously published discussions ('What is the true impact of cognitive impairment for people living with multiple sclerosis? A commentary of symposium discussions at the 2020 European Charcot Foundation') from the 2020 European Charcot Foundation meeting between a patient expert living with MS, a neuropsychologist and a neurologist about the impact of cognitive impairment on people living with MS. These discussions highlighted that cognitive impairment may be under-prioritised in MS care and has a substantial impact on the daily lives of people living with MS. To address this, the panel recommended improved awareness about impaired cognition in MS, improved communication between people living with MS and healthcare professionals, and routine cognition screening. This will help improve management of cognitive symptoms to maximise the quality of life of people living with MS.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Idioma: En Revista: Neurol Ther Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Idioma: En Revista: Neurol Ther Ano de publicação: 2024 Tipo de documento: Article